Table 2.
Serum MT-1 Protein Levels in the Presence or Absence of as Clinical Characteristics
| Clinical Characteristics | n | Present Median (Interquartile Range) | n | Absent Median (Interquartile Range) | P- value |
|---|---|---|---|---|---|
| Osteoporosis | 31 | 514.35(400.12 to 643.39) | 36 | 374.26(214.15 to 456.21) | <0.0001 |
| Hypertension | 21 | 441.16(287.12 to 525.37) | 46 | 413.78(314.29 to 564.13) | ns |
| Hyperlipidemia | 8 | 454.81(248.19 to 500.99) | 59 | 417.36(314.29 to 549.25) | ns |
| Liver dysfunction | 25 | 415.19(345.13 to 528.36) | 42 | 440.42(287.12 to 549.25) | ns |
| Kidney dysfunction | 20 | 428.18(345.49 to 549.14) | 47 | 417.36(264.13 to 538.64) | ns |
| Leukocytosis | 7 | 467.46(168.55 to 528.36) | 60 | 416.27(314.29 to 549.14) | ns |
| Polycythemia | 10 | 448.69(394.26 to 527.46) | 57 | 415.19(295.72 to 549.14) | ns |
Notes: Differences between two groups were performed with unpaired Student’s t-test for nonparametric data. P< 0.05 represents a significant difference.
Abbreviation: NS, not significant.